BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bigna JJ, Kenne AM, Asangbeh SL, Sibetcheu AT. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. Lancet Glob Health 2018;6:e193-202. [PMID: 29254748 DOI: 10.1016/S2214-109X(17)30451-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Singhvi D, Bon J, Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis. Curr HIV/AIDS Rep 2019;16:359-69. [PMID: 31256349 DOI: 10.1007/s11904-019-00456-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
2 MacDonald DM, Zanotto AD, Collins G, Baker JV, Czarnecki M, Loiza E, Nixon DE, Papastamopoulos V, Wendt CH, Wood R, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Associations between baseline biomarkers and lung function in HIV-positive individuals. AIDS 2019;33:655-64. [PMID: 30601153 DOI: 10.1097/QAD.0000000000002101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
3 Yang Z, Zhu Z, Lizarondo L, Xing W, Han S, Hu H, Hu Y, Wu B. Experience of chronic noncommunicable disease in people living with HIV: a systematic review and meta-aggregation of qualitative studies. BMC Public Health 2021;21:1651. [PMID: 34507576 DOI: 10.1186/s12889-021-11698-5] [Reference Citation Analysis]
4 Vanfleteren LEGW, Ullman A, Nordenson A, Andersson A, Andelid K, Fabbri LM. Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box. ERJ Open Res 2019;5:00185-2018. [PMID: 30775372 DOI: 10.1183/23120541.00185-2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kovacs L, Kress TC, Belin de Chantemèle EJ. HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women. JACC Basic Transl Sci 2022;7:410-21. [PMID: 35540101 DOI: 10.1016/j.jacbts.2021.10.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sehl ME, Breen EC, Shih R, Chen L, Wang R, Horvath S, Bream JH, Duggal P, Martinson J, Wolinsky SM, Martinez-maza O, Ramirez CM, Jamieson BD. Increased Rate of Epigenetic Aging in Men Living With HIV Prior to Treatment. Front Genet 2022;12:796547. [DOI: 10.3389/fgene.2021.796547] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gilbert RF, Cichowitz C, Bibangambah P, Kim JH, Hemphill LC, Yang IT, Sentongo RN, Kakuhikire B, Christiani DC, Tsai AC, Okello S, Siedner MJ, North CM. Lung function and atherosclerosis: a cross-sectional study of multimorbidity in rural Uganda. BMC Pulm Med 2022;22:12. [PMID: 34983492 DOI: 10.1186/s12890-021-01792-0] [Reference Citation Analysis]
8 Turner CT, Brown J, Shaw E, Uddin I, Tsaliki E, Roe JK, Pollara G, Sun Y, Heather JM, Lipman M, Chain B, Noursadeghi M. Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment. Front Immunol 2021;12:634489. [PMID: 33732256 DOI: 10.3389/fimmu.2021.634489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Varkila MRJ, Vos AG, Barth RE, Tempelman HA, Devillé WLJ, Coutinho RA, Grobbee DE, Klipstein-Grobusch K. The association between HIV infection and pulmonary function in a rural African population. PLoS One 2019;14:e0210573. [PMID: 30645622 DOI: 10.1371/journal.pone.0210573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Ddungu A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, Worodria W, Kirenga BJ. Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country. PLoS One 2021;16:e0256121. [PMID: 34388209 DOI: 10.1371/journal.pone.0256121] [Reference Citation Analysis]
11 Hessol NA, Barrett BW, Margolick JB, Plankey M, Hussain SK, Seaberg EC, Massad LS. Risk of smoking-related cancers among women and men living with and without HIV. AIDS 2021;35:101-14. [PMID: 33048871 DOI: 10.1097/QAD.0000000000002717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Robertson NM, Nagourney EM, Pollard SL, Siddharthan T, Kalyesubula R, Surkan PJ, Hurst JR, Checkley W, Kirenga BJ. Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in Uganda. Chronic Obstr Pulm Dis 2019;6:17-28. [PMID: 30775421 DOI: 10.15326/jcopdf.6.1.2018.0143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
13 Zifodya JS, Ferguson TF, Siggins RW, Brashear MM, Kantrow SP, Nelson S, Shellito JE, Molina PE, Welsh DA. Cross sectional analysis of the effect of alcohol on pulmonary function in a cohort of men and women living with HIV. Alcohol 2022;101:45-51. [PMID: 35306109 DOI: 10.1016/j.alcohol.2022.03.001] [Reference Citation Analysis]
14 Yang HY, Beymer MR, Suen SC. Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset. Sci Rep 2019;9:18514. [PMID: 31811207 DOI: 10.1038/s41598-019-54969-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
15 Psomas C, Kinloch S, Sabin C, Soriano V, Solas C, Orkin C, Bernardino J, Curran A, Routy J, Enel P, Philibert P, Lafeuillade A. Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16–18 May 2018, Marseille, France: from HIV and comorbidities to global health. Journal of Virus Eradication 2018;4:196-207. [DOI: 10.1016/s2055-6640(20)30271-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Kajogoo VD, Twebaze C, Said B, Tesfahunei HA, Charlie L, Getachew E. Post tuberculosis chronic lung disease in tuberculosis HIV coinfected and non-HIV individuals in Sub-Saharan Africa: A systematic review and meta-analysis. Int J Mycobacteriol 2022;11:139-44. [PMID: 35775545 DOI: 10.4103/ijmy.ijmy_66_22] [Reference Citation Analysis]
17 Zhang B, Zhou F, Hong J, Ng DM, Yang T, Zhou X, Jin J, Zhou F, Chen P, Xu Y. The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis. World J Surg Oncol 2021;19:182. [PMID: 34154596 DOI: 10.1186/s12957-021-02291-6] [Reference Citation Analysis]
18 Siddiqi KA, Ostermann J, Zhang J, Khan MM, Olatosi B. Ageing with HIV in the United States: Changing trends in inpatient hospital stays and comorbidities, 2003-2015. HIV Med 2022. [PMID: 35674220 DOI: 10.1111/hiv.13325] [Reference Citation Analysis]
19 Tadyanemhandu C, Mupanda C, Dambi J, Chiwaridzo M, Chikwasha V, Chengetanai S. Human immunodeficiency virus associated pulmonary conditions leading to hospital admission and the pulmonary rehabilitation services received by patients at two central hospitals in Harare. BMC Res Notes 2018;11:407. [PMID: 29941015 DOI: 10.1186/s13104-018-3525-0] [Reference Citation Analysis]
20 Cristinziano L, Poto R, Criscuolo G, Ferrara AL, Galdiero MR, Modestino L, Loffredo S, de Paulis A, Marone G, Spadaro G, Varricchi G. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. Cells 2021;10:145. [PMID: 33445787 DOI: 10.3390/cells10010145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Kalmin MM, Westreich D, Drummond BM, Sun J, Mehta SH, Kirk GD. Incident obstructive lung disease and mortality among people with HIV and a history of injecting drugs. AIDS 2021;35:1451-60. [PMID: 33831913 DOI: 10.1097/QAD.0000000000002914] [Reference Citation Analysis]
22 Jespersen NA, Axelsen F, Dollerup J, Nørgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era. HIV Med 2021;22:478-90. [PMID: 33645000 DOI: 10.1111/hiv.13077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kunisaki KM, Baker JV, Collins G, MacDonald DM, Bakowska E, El Filali KM, Nnakelu E, La Rosa A, Connett JE. Lung Function Decline in Early HIV Infection: Impact of Antiretroviral Drug Timing and Drug Regimen. Am J Respir Crit Care Med 2020;201:739-41. [PMID: 31841641 DOI: 10.1164/rccm.201911-2266LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Marone G, Rossi FW, Pecoraro A, Pucino V, Criscuolo G, Paulis A, Spadaro G, Marone G, Varricchi G. HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. Vaccines (Basel) 2020;8:E208. [PMID: 32375243 DOI: 10.3390/vaccines8020208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
25 Kunisaki KM, Nouraie M, Jensen RL, Chang D, D'Souza G, Fitzpatrick ME, McCormack MC, Stosor V, Morris A. Lung function in men with and without HIV. AIDS 2020;34:1227-35. [PMID: 32287070 DOI: 10.1097/QAD.0000000000002526] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
26 Ale BM, Amahowe F, Nganda MM, Danwang C, Wakaba NN, Almuwallad A, Ale FBG, Sanoussi A, Abdullahi SH, Bigna JJ. Global burden of active smoking among people living with HIV on antiretroviral therapy: a systematic review and meta-analysis. Infect Dis Poverty 2021;10:12. [PMID: 33579391 DOI: 10.1186/s40249-021-00799-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 MacDonald DM, Collins G, Wendt CH, Wolfson J, Tracy RP, Rhame F, Deeks S, Rizza SA, Temesgen Z, Morse C, Liappis AP, Sereti I, Baker JV, Kunisaki KM. Short Communication: A Pilot Study of the Effects of Losartan Versus Placebo on Pneumoproteins in HIV: A Secondary Analysis of a Randomized Double Blind Study. AIDS Res Hum Retroviruses 2022;38:127-30. [PMID: 33749317 DOI: 10.1089/AID.2020.0285] [Reference Citation Analysis]
28 Alexandrova Y, Costiniuk CT, Jenabian MA. Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection. Front Immunol 2021;12:808722. [PMID: 35058937 DOI: 10.3389/fimmu.2021.808722] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nansseu JR, Tounouga DN, Noubiap JJ, Bigna JJ. Changes in smoking patterns after HIV diagnosis or antiretroviral treatment initiation: a global systematic review and meta-analysis. Infect Dis Poverty 2020;9:35. [PMID: 32295634 DOI: 10.1186/s40249-020-00644-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zifodya JS, Triplette M, Shahrir S, Attia EF, Akgun KM, Soo Hoo GW, Rodriguez-Barradas MC, Wongtrakool C, Huang L, Crothers K. A cross-sectional analysis of diagnosis and management of chronic obstructive pulmonary disease in people living with HIV: Opportunities for improvement. Medicine (Baltimore) 2021;100:e27124. [PMID: 34664836 DOI: 10.1097/MD.0000000000027124] [Reference Citation Analysis]
31 Harrington KRV, Staitieh BS, Nguyen MLT, Colasanti JA, Sumitani J, Marconi VC, Auld SC. Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting. AIDS Patient Care STDS 2021;35:239-48. [PMID: 34242091 DOI: 10.1089/apc.2021.0020] [Reference Citation Analysis]
32 Wang RJ, Nouraie M, Kunisaki KM, Huang L, Tien PC, Anastos K, Bhandari N, Bhatt SP, Bolivar H, Cribbs SK, Foronjy R, Gange SJ, Lazarous D, Morris A, Drummond MB. Lung Function in Women with and without HIV. Clin Infect Dis 2022:ciac391. [PMID: 35604821 DOI: 10.1093/cid/ciac391] [Reference Citation Analysis]
33 Johnston R. What Might Surviving Coronavirus Disease 2019 Look Like for People Living with HIV? AIDS Patient Care STDS 2021;35:1-4. [PMID: 33347338 DOI: 10.1089/apc.2020.29006.com] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Head BM, Mao R, Keynan Y, Rueda ZV. Inflammatory mediators and lung abnormalities in HIV: A systematic review. PLoS One 2019;14:e0226347. [PMID: 31830103 DOI: 10.1371/journal.pone.0226347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Antoniou T, Yao Z, Raboud J, Gershon AS. Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study. CMAJ Open 2020;8:E83-9. [PMID: 32071142 DOI: 10.9778/cmajo.20190028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Watson WH, Ritzenthaler JD, Peyrani P, Wiemken TL, Furmanek S, Reyes Vega AM, Burke TJ, Zheng Y, Ramirez JA, Roman J. Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients. Free Radic Biol Med 2019;143:55-61. [PMID: 31369840 DOI: 10.1016/j.freeradbiomed.2019.07.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
37 Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. The Lancet Respiratory Medicine 2022;10:497-511. [DOI: 10.1016/s2213-2600(21)00506-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
38 Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, Szabo J, Haraoui LP, de Pokomandy A, Tsoukas C, Falutz J, LeBlanc R, Giannakis A, Frenette C, Jenabian MA, Bourbeau J, Klein MB. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study. HIV Med 2019;20:192-201. [PMID: 30620136 DOI: 10.1111/hiv.12699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Brown J, Pickett E, Smith C, Sachikonye M, Brooks L, Mahungu T, Lowe DM, Madge S, Youle M, Johnson M, Hurst JR, McHugh TD, Abubakar I, Lipman M. The effect of HIV status on the frequency and severity of acute respiratory illness. PLoS One 2020;15:e0232977. [PMID: 32469981 DOI: 10.1371/journal.pone.0232977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Johnston PI, Wright SW, Orr M, Pearce FA, Stevens JW, Hubbard RB, Collini PJ. Worldwide relative smoking prevalence among people living with and without HIV. AIDS 2021;35:957-70. [PMID: 33470609 DOI: 10.1097/QAD.0000000000002815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
42 Shiau S, Bender AA, O'Halloran JA, Sundermann E, Aggarwal J, Althoff KN, Baker JV, Deeks S, Fried LP, Karpiak S, Karris MY, Marcotte TD, Nachega JB, Margolick JB, Erlandson KM, Moore DJ. The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging. AIDS Res Hum Retroviruses 2020;36:973-81. [PMID: 32847368 DOI: 10.1089/AID.2020.0128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
43 Abdool-Gaffar MS, Calligaro G, Wong ML, Smith C, Lalloo UG, Koegelenberg CFN, Dheda K, Allwood BW, Goolam-Mahomed A, van Zyl-Smit RN. Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update. J Thorac Dis 2019;11:4408-27. [PMID: 31903229 DOI: 10.21037/jtd.2019.10.65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy. J Acquir Immune Defic Syndr 2018;79:e85-92. [PMID: 29985804 DOI: 10.1097/QAI.0000000000001797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]